Search

everythinglearnresearchcommunity

for

Search:↓

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

The Wnt/β-catenin pathway is important for tissue development and has potential in regenerative medicine, but requires more research for therapeutic use.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Stem cells are crucial for tissue growth, cancer treatment, and disease modeling, but challenges remain in clinical use.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Hair grays due to oxidative stress and fewer functioning melanocytes.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Progress has been made in skin and nerve regeneration, but more research is needed to improve methods and ensure safety.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Stem cells help repair tissue mainly by releasing beneficial substances, not by replacing damaged cells.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Certain diets can affect skin conditions, but more research is needed to understand these relationships fully.

New treatments aim to improve thin endometrium to help more couples with infertility.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Using steroids can increase the risk of heart problems.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

PDGF signaling is crucial for maintaining and renewing hair follicle stem cells, which could help treat hair loss.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.